NALFON
Xspire Pharma, Llc
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88102267 |
| Registration Number | 5744460 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Law Office Assigned | L70 |
| Employee Name | CLARK, ANDREW T |
Timeline
| 2012-01-01 | Date of First Use |
| 2018-09-02 | Application Filed |
| 2019-02-19 | Published for Opposition |
| 2019-05-07 | Location: PUBLICATION AND ISSUE SECTION |
| 2019-05-07 | Status: Live/Registered |
| 2019-05-07 | Trademark Registered |
| 2019-10-31 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  XSPIRE PHARMA, LLC |
| Address | 121 MARKETRIDGE DR. SUITE B RIDGELAND MS 39157 |
| Legal Entity Type | Limited Liability Company |
| Legal Entity State | MS |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations, namely, prescription drugs for treating pain and inflammation; Pharmaceutical preparations, namely, prescription nonsteroidal anti-inflammatory drugs (NSAID) for treating pain and inflammation; Prescription analgesic to relieve pain and inflammation |
| GS0051 | Pharmaceutical preparations, namely, prescription drugs for treating pain and inflammation; Pharmaceutical preparations, namely, prescription nonsteroidal anti-inflammatory drugs (NSAID) for treating pain and inflammation; Prescription analgesic to relieve pain and inflammation |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2018-09-05 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-09-11 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2018-12-14 | 3 DOCK D:Assigned to Examiner |
| EXAMINERS AMENDMENT -WRITTEN | 2018-12-18 | 4 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2018-12-18 | 5 GNEA F:First Action |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2018-12-18 | 6 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2018-12-18 | 7 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-12-18 | 8 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2019-01-11 | 9 ALIE A:Allowance for Publication |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-01-30 | 10 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2019-02-19 | 11 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-02-19 | 12 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2019-05-07 | 13 R.PR A:Allowance for Publication |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2019-10-30 | 14 ASGN I:Incoming Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-10-27 | 15 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-10-27 | 16 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-10-27 | 17 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-10-27 | 18 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-10-27 | 19 CHAN I:Incoming Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 NALFON 88102267 5744460 Live/Registered |
XSPIRE PHARMA, LLC 2018-09-02 |
 NALFON 88035642 not registered Dead/Abandoned |
Galt Pharmaceuticals, LLC 2018-07-12 |
 NALFON 72442005 0974831 Dead/Cancelled |
ELI LILLY AND COMPANY 1972-11-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 